August 31, 2026 Uncategorized BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee Read More
August 28, 2026 Uncategorized BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants Read More
August 24, 2026 Uncategorized BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants Read More
August 19, 2026 Uncategorized BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer Read More